We received back the results of Tom's Prostate Biopsy and they did identify cancer in 3/15 core samples taken. The doctors ...

This important study describes a deep learning framework that analyzes single-cell RNA data to identify a tumor-agnostic gene signature associated with brain metastases. The identified signature ...

IO360º today announced the 2026 sponsoring companies of the 12th annual Immuno-Oncology 360º Summit (IO360°) to date, who provide the capabilities the IO marketplace needs to advance the science.

The Hepatitis B and C Therapeutics Market has entered a renewed growth cycle in 2024, led by innovative antiviral regimens, expanded national vaccination programs, accelerated screening, and renewed ...

Jefferies London Healthcare Conference 2025 November 17, 2025 10:00 AM ESTCompany ParticipantsLawrence Blatt - ...

Molecular profiling is key in precision oncology research and whilst the tissue testing has become a routine, liquid biopsy might provide a non-invasive alternative when tissue biopsy is inaccessible.

Astute Analytica stands out as a premier provider of comprehensive Bronchial Biopsy Devices Market research reports specifically tailored for the healthcare sector. Our commitment lies in delivering ...

Designed to generate data and outcomes on bone and muscle health in both healthy people and those with disease, a novel ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, said it was recently approved by ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...

The organoid core strengthens the Cawley Center's research capabilities by enabling drug screening and biomarker discovery. It will bank organoids representing the wide variety of tumors seen in the ...

A Kingston research team has created a patented 3D-printed surgical biopsy tool that allows scientists to map and study ...